Company Filing History:
1 out of 443 
1 out of 2,893 
1 out of 2,963 
Years Active: 2021
Title: Hanna Meyer: Innovator in Hematological Cancer Treatment
Introduction
Hanna Meyer is a distinguished inventor based in Berlin, Germany. She has made significant contributions to the field of medicine, particularly in the treatment of hematological cancers. Her innovative work has led to the development of methods that can potentially improve patient outcomes in acute myeloid leukemia.
Latest Patents
Hanna Meyer holds one patent titled "Compounds and methods useful for treating or preventing hematological cancers." This invention includes methods of treating patients with acute myeloid leukemia across a range of genetic subtypes using DHODH inhibitors, such as 6-fluoro-2-(2'-fluoro-[1,1′-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid. This groundbreaking work showcases her commitment to advancing cancer treatment.
Career Highlights
Throughout her career, Hanna Meyer has worked with prominent organizations, including the Broad Institute, Inc. and the General Hospital Corporation. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in medical research.
Collaborations
Hanna has collaborated with notable colleagues, including David B. Sykes and David T. Scadden. These partnerships have enriched her research and expanded the impact of her innovations in the medical community.
Conclusion
Hanna Meyer is a remarkable inventor whose work in hematological cancer treatment is paving the way for new therapeutic approaches. Her dedication to improving patient care through innovative methods is commendable and highlights the importance of research in the fight against cancer.